Verified batch-to-batch consistency, full analytical dossiers (COA/HPLC), and direct cGMP contract factory supply.
Gynostemma pentaphyllum (Thunb.) Makino (commonly referred to in classical pharmacopoeias as Jiaogulan or "Southern Ginseng") is a herbaceous dioecious climbing vine belonging to the Cucurbitaceae family. While taxonomically distinct from Araliaceae (true ginsengs), Jiaogulan is distinctively characterized by its rich biosynthesis of dammarane-type triterpenoid saponins, officially cataloged as gypenosides. To date, analytical profiling via High-Resolution Electrospray Ionization Mass Spectrometry (HR-ESI-MS) has identified over 180 individual gypenoside fractions within the aerial parts of the botanical.
Notably, several major gypenosides share complete chemical isomerism and identity with classical panaxadiol saponins. Gypenoside III is chemically identical to Ginsenoside Rb1, Gypenoside IV corresponds to Ginsenoside Rb3, and Gypenoside VIII matches Ginsenoside Rd. This provides brand formulators with adaptogenic potency equivalent or superior to Panax ginseng, but with enhanced cellular safety and clean-taste formulation economics.
The pharmacological centerpiece of standardized Gynostemma pentaphyllum extract lies in its proven capacity to induce allosteric activation of 5' adenosine monophosphate-activated protein kinase (AMPK). Phosphorylation of the Thr172 residue on the AMPK α-catalytic subunit down-regulates sterol regulatory element-binding protein 1c (SREBP-1c) and acetyl-CoA carboxylase (ACC), promoting accelerated lipid catabolism and cellular ATP regeneration.
Industrial performance originates in botanical agronomy. Prime Gynostemma crops are sourced from high-altitude microclimates in Shaanxi (Qinling-Bashan Mountain corridor). The endemic soil mineral equilibrium, characterized by bioavailable selenium, neutral pH, and prolonged cloud-cover dispersal, yields raw folium with total primary saponin concentrations exceeding 8.5% w/w prior to primary factory processing.
The international market valuation for botanical extracts modulating metabolic and glycemic parameters surpassed USD 38.4 billion in 2024, with standardized Gynostemma pentaphyllum formulations demonstrating a Compound Annual Growth Rate (CAGR) of 8.2% through 2032. This global acceleration is fueled by two distinct macroeconomic shifts: the clinical mainstreaming of metabolic syndrome prevention and the explosive demand for non-synthetic longevity supplements (AMPK / Sirtuin mimetics).
With the commercial ascendance of pharmaceutical GLP-1 receptor agonists, consumer demand has surged for natural "maintenance and weaning" nutraceutical regimens. Tier-1 brands position high-concentration Gypenoside formulations (such as Gypenoside XLIX and Damulin B) to enhance post-prandial glycemic clearance, suppress lipogenesis, and mitigate lean muscle catabolism via insulin receptor substrate-1 (IRS-1) sensitization.
Historically, global procurement suffered from erratic wildcrafting practices, adulteration with lower-grade Cucurbita foliage, and unacceptable agrochemical residues. Modern contract procurement requires qualified factory operations demonstrating vertical GAP plantation governance, certified absence of organochlorine pesticides, and complete elimination of carcinogenic polycyclic aromatic hydrocarbons (PAH4).
A critical technical chasm persists in raw material commercialization: the divergence between total saponins measured by non-specific UV-Vis spectrophotometry (vanillin-perchloric acid method) versus quantitative HPLC-ELSD / LC-MS identification of target gypenoside fractions. Premier ODM manufacturers standardise strictly against quantified peak markers, protecting global buyers from false-positive assay dilution.
At our centralized Xi'an processing facility, Gynostemma pentaphyllum leaf biomass undergoes a rigorous multi-stage separation pipeline engineered to maximize saponin recovery while eliminating thermolabile degradation and residual solvent traces.
Pre-milled raw leaves (mesh size 20–40) are subjected to continuous dynamic counter-current solid-liquid extraction using food-grade azeotropic hydro-ethanol (60–75% v/v) at an operating temperature strictly controlled between 50°C and 55°C. This prevents the thermal cleaving of glycosidic ester bonds typical of antiquated batch boiling methods.
The primary crude micellar liquor is passed through ceramic cross-flow membrane assemblies (pore cutoff: 50–100 kDa) to selectively strip away high-molecular-weight polysaccharides, pectin, polyphenolic tannins, and chloroplastic pigments without compromising the solubility index of target triterpenoid glycosides.
Desolventized retentate is fed into a validated industrial chromatographic column packed with non-polar synthetic styrene-divinylbenzene resin (AB-8 / D101). Non-target polar sugars are purged via demineralized water flushing, followed by graded ethanol desorption to elute gypenoside fractions from 40% up to 98% purity.
Eluates are concentrated through low-temperature falling-film vacuum evaporators (<48°C) down to 22–26° Brix. Spray atomization within a cleanroom suite (ISO Class 8) preserves crystal morphometry, delivering off-white to pale-yellow micro-granules with rapid water solubility (<45 seconds at 20°C).
Precision analytical grades engineered for functional beverages, solid capsules, transdermal cosmetics, and clinical dietary supplements.
| Standard Grade | Assay Method | Target Biomarkers | Physical Form | Moisture / Ash | Key Application |
|---|---|---|---|---|---|
| Gynostemma Extract 20% | UV-Vis / HPLC | Total Gypenosides ≥20.0% | Fine Brownish Powder | ≤5.0% / ≤6.0% | Instant Functional Teas, RTD Beverages |
| Gynostemma Extract 40% | UV-Vis | Total Saponins ≥40.0% | Yellow-Brown Powder | ≤5.0% / ≤5.0% | Tableting, Hard Gelatin Capsules |
| Gynostemma Extract 80% | UV-Vis / HPLC | Total Gypenosides ≥80.0% | Light Yellow Powder | ≤4.0% / ≤3.0% | Premium AMPK Formulations, Longevity Blends |
| Gynostemma Extract 98% | HPLC-ELSD | Gypenoside XLIX / Total ≥98.0% | Off-White Fine Powder | ≤3.0% / ≤1.0% | Pharma Clinical Research, High-End Cosmeceuticals |
| De-Bittered Instant Grade | HPLC | Total Gypenosides ≥30.0% | Free-Flowing Granules | ≤4.0% / ≤4.0% | Direct Sachet Blends, Dissolvable Sticks |
Navigating regulatory frameworks requires specialized manufacturing and analytical documentation. Xi'an Le-Nutra develops market-specific dossiers addressing the exact compliance standards of each major target jurisdiction.
Classified under DSHEA as a dietary supplement ingredient. Formulations comply with 21 CFR Part 111 cGMP standards. We provide comprehensive heavy metal testing satisfying California Proposition 65 thresholds (Pb < 0.5 mcg/day, As < 10 mcg/day, Cd < 4.1 mcg/day) alongside USP <561> multi-residue pesticide documentation.
Requires strict differentiation between Traditional Herbal Medicinal Products (THMPD) and Novel Food status (EC No 2015/2283). We supply batch testing conforming to European Pharmacopoeia (EP 2.8.13) pesticide regulations, PAH4 limits below 10 ppb (EU 2015/1933), and non-detectable ethylene oxide (<0.01 mg/kg).
Complies with Japanese Consumer Affairs Agency FFC (Foods with Function Claims) criteria for fat metabolism support, as well as South Korean MFDS Health Functional Food (HFF) monographs. Chinese GB2762-2022 heavy metal and microbial safety criteria are fully satisfied across all released production lots.
Standardized Gynostemma pentaphyllum extract (INCI name: Gynostemma Pentaphyllum Leaf/Stem Extract) is widely incorporated into anti-aging serums and barrier creams. Topical Gypenoside XLIX inhibits UV-induced matrix metalloproteinase-1 (MMP-1), protecting dermal collagen architectures from photo-damage.
As natural product pharmacology advances into precision medicine and nano-therapeutics, Xi'an Le-Nutra's internal R&D facilities are engineering next-generation delivery vehicles to overcome the intrinsic oral bioavailability hurdles of bulky triterpenoid glycosides.
Natural botanical tissues produce high quantities of glycosylated multi-sugar saponins, while the most pharmacologically active fractions (e.g., Gypenoside LXXV, Damulin A, Damulin B) exist only in sub-0.05% traces. Our team deploys food-grade β-glucosidases and recombinant arabinofuranosidases to selectively cleave terminal monosaccharides, enriching rare Damulin titers by up to 1,200%.
Due to excessive molecular weights (MW > 900 Da) and high hydrogen-bonding potential, native gypenosides exhibit oral bioavailability below 3.5% across intestinal enterocytes. Our engineered phytosome complex binds pure gypenosides to hydrogenated phosphatidylcholine at a 1:2 molar ratio, enhancing passive lymphatic uptake and doubling plasma AUC in human trials.
In partnership with university laboratories in Shaanxi, we are operationalizing an industrial-scale Supercritical Fluid Extraction (SFE-CO2) line utilizing ethanol as an environmental co-solvent. This allows total recovery of non-polar dammarane sapogenins with completely zero hazardous effluent, delivering an ultra-clean label standard for European organic buyers.
Modern international brand owners require more than bulk powder containers. Xi'an Le-Nutra operates as a comprehensive contract manufacturing and ODM engine, transforming active phytochemistry into retail-ready product realities across six specialized production lines.
Need a formulation standardized specifically to Gypenoside XLIX for cardiac nitric oxide activation? Or a de-saponified flavonoid fraction for antioxidant beverage integration? Our pilot R&D line produces custom-tailored extraction profiles, adapting solvent systems and resin gradients to hit your precise chemical targets.
Our 60,000 m² cGMP facility runs high-speed automated capsule encapsulation (sizes 00, 0, 1), precision rotary tableting with enteric polymer coatings, and sachet stick packaging for instant dissolvable beverage applications, complete with tamper-evident induction sealing and batch printing.
Every commercial delivery includes an exhaustive technical release dossier: Batch Certificate of Analysis (COA) specifying validated HPLC methods, Safety Data Sheet (SDS/MSDS), TSE/BSE declarations, non-GMO statements, Halal and Kosher certifications, and third-party lab verification from SGS or Eurofins upon request.
Key regulatory, chemical, and commercial questions answered for ingredient formulators, analytical chemists, and enterprise procurement directors.
Expand your product development portfolio with high-purity cosmetic actives, vegetal peptides, and specialized nutritional compounds.
Typical reply within one business day (UTC+8).
[email protected] +86-29-86518603 Request a Catalog Contact us